27846748|t|Beneficial effects of natural eggshell membrane (NEM) on multiple indices of arthritis in collagen-induced arthritic rats
27846748|a|This study was performed to evaluate the potential efficacy of natural eggshell membrane (NEM) in collagen-induced arthritic rats, a well-established rodent model of inflammation and rheumatoid arthritis. Rats with developing type II collagen-induced arthritis (CIA) were treated once daily by oral gavage on study days -14 to 17 with vehicle or NEM (52 mg/kg body weight). Rats were euthanized on study day 17. Efficacy was assessed by daily ankle caliper measurements, ankle diameter expressed as area under the curve (AUCd0-17), and histopathologic evaluation of ankles and knees. Serum biomarkers of cartilage function and inflammation [collagen type II C-telopeptide (CTXII), cartilage oligomeric matrix protein (COMP), and alpha-2-macroglobulin (A2M)] were measured by ELISA. Treatment with NEM resulted in significant beneficial effects on the daily ankle diameter measurements and ankle diameter AUC. Ankle and knee histopathology scores were significantly reduced (36% and 43% reduction of summed individual histopathology scores for ankle and knee, respectively; p < 0.05) toward normal for rats given NEM compared to vehicle controls. The percent reduction of serum CTXII, COMP, and A2M in NEM - treated rats ranged from 30% to 72% (p < 0.05). NEM significantly improved multiple aspects of inflammatory arthritis including inflammation, pannus, cartilage damage, bone resorption, and periosteal bone formation. This study provides further support for the use of CTXII, COMP, and A2M as relevant biomarkers that were responsive to NEM.
27846748	0	18	Beneficial effects	UnknownType	C0683156
27846748	22	47	natural eggshell membrane	T109,T121	C3651790
27846748	49	52	NEM	T109,T121	C3651790
27846748	77	86	arthritis	T047	C0003864
27846748	90	116	collagen-induced arthritic	T050	C0971858
27846748	117	121	rats	T015	C0034721
27846748	127	132	study	T062	C2603343
27846748	150	158	evaluate	T058	C0220825
27846748	163	181	potential efficacy	T080	C1280519
27846748	185	210	natural eggshell membrane	T109,T121	C3651790
27846748	212	215	NEM	T109,T121	C3651790
27846748	220	246	collagen-induced arthritic	T050	C0971858
27846748	247	251	rats	T015	C0034721
27846748	272	300	rodent model of inflammation	T050	C1519106
27846748	305	325	rheumatoid arthritis	T047	C0003873
27846748	327	331	Rats	T015	C0034721
27846748	348	382	type II collagen-induced arthritis	T050	C0971858
27846748	384	387	CIA	T050	C0971858
27846748	407	412	daily	T079	C0332173
27846748	416	427	oral gavage	T169	C2698653
27846748	431	441	study days	T079	C2826182
27846748	457	464	vehicle	T122	C0042444
27846748	468	471	NEM	T109,T121	C3651790
27846748	482	493	body weight	T032	C0005910
27846748	496	500	Rats	T015	C0034721
27846748	506	516	euthanized	T062	C2983562
27846748	520	529	study day	T079	C2826182
27846748	534	542	Efficacy	T080	C1280519
27846748	547	555	assessed	T052	C1516048
27846748	559	564	daily	T079	C0332173
27846748	565	570	ankle	T029	C0003086
27846748	571	578	caliper	T074	C0175720
27846748	579	591	measurements	T169	C0242485
27846748	579	591	measurements	T169	C0242485
27846748	593	598	ankle	T029	C0003086
27846748	599	607	diameter	T081	C1301886
27846748	621	641	area under the curve	T081	C0376690
27846748	643	651	AUCd0-17	T081	C0376690
27846748	658	684	histopathologic evaluation	T091	C0677043
27846748	688	694	ankles	T029	C0003086
27846748	699	704	knees	T023	C0022742
27846748	706	711	Serum	T031	C0229671
27846748	712	722	biomarkers	T201	C0005516
27846748	726	744	cartilage function	T042	C0231581
27846748	749	761	inflammation	T046	C0021368
27846748	763	793	collagen type II C-telopeptide	T059	C2825914
27846748	795	800	CTXII	T059	C2825914
27846748	803	838	cartilage oligomeric matrix protein	T059	C3715143
27846748	840	844	COMP	T059	C3715143
27846748	851	872	alpha-2-macroglobulin	T059	C0523483
27846748	874	877	A2M	T059	C0523483
27846748	885	893	measured	T080	C0444706
27846748	897	902	ELISA	T059	C0014441
27846748	904	913	Treatment	T169	C0039798
27846748	919	922	NEM	T109,T121	C3651790
27846748	935	965	significant beneficial effects	UnknownType	C0683156
27846748	973	978	daily	T079	C0332173
27846748	979	984	ankle	T029	C0003086
27846748	985	993	diameter	T081	C1301886
27846748	994	1006	measurements	T169	C0242485
27846748	1011	1016	ankle	T029	C0003086
27846748	1017	1025	diameter	T081	C1301886
27846748	1026	1029	AUC	T081	C0376690
27846748	1031	1036	Ankle	T029	C0003086
27846748	1041	1045	knee	T023	C0022742
27846748	1046	1067	histopathology scores	T034	C0428093
27846748	1073	1094	significantly reduced	T080	C0392756
27846748	1108	1117	reduction	T080	C0392756
27846748	1139	1160	histopathology scores	T034	C0428093
27846748	1165	1170	ankle	T029	C0003086
27846748	1175	1179	knee	T023	C0022742
27846748	1223	1227	rats	T015	C0034721
27846748	1234	1237	NEM	T109,T121	C3651790
27846748	1293	1298	serum	T031	C0229671
27846748	1299	1304	CTXII	T059	C2825914
27846748	1306	1310	COMP	T059	C3715143
27846748	1316	1319	A2M	T059	C0523483
27846748	1323	1326	NEM	T109,T121	C3651790
27846748	1329	1336	treated	T169	C1522326
27846748	1337	1341	rats	T015	C0034721
27846748	1377	1380	NEM	T109,T121	C3651790
27846748	1424	1446	inflammatory arthritis	T047	C0003864
27846748	1457	1469	inflammation	T046	C0021368
27846748	1471	1477	pannus	T046	C0333350
27846748	1479	1495	cartilage damage	T037	C0549421
27846748	1497	1512	bone resorption	T042	C0005974
27846748	1518	1543	periosteal bone formation	T042	C0231565
27846748	1550	1555	study	T062	C2603343
27846748	1596	1601	CTXII	T116	C0631180
27846748	1603	1607	COMP	T116,T123	C0601900
27846748	1613	1616	A2M	T116,T123	C0002198
27846748	1629	1639	biomarkers	T201	C0005516
27846748	1664	1667	NEM	T109,T121	C3651790